Short description
OxSyBio is developing 3D printing techniques to produce a range of tissue-like & functional tissues for medical research.
Description
OxSyBio's vision is to ultimately produce tissues that can be used by patients in the clinic for precision medicine and organ repair or replacement. At OxSyBio, they are developing 3D printing techniques to produce a range of tissue-like and functional tissues for medical research and clinical applications.
Their technology is based on cutting-edge research conducted by Professor Hagan Bayley’s group in the Chemistry Department at the University of Oxford. A leader in the exploration of chemical and synthetic biology his expertise cover membrane protein structure and function, single molecule chemistry and 3D printing.
Last funding
Uh Ohhhh
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
London, England, United Kingdom, Europe
Founded on
January 1, 2014
Closed on
January 1, 2019
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$34056 - 789030
Sign in for full access
Investors
Cannot Access, Noaccess, Cannot Access, No Way
Sign in for full access
Founders
Hagan Bayley